Clinical Progress of Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Journal Title: Diseases & Research - Year 2021, Vol 1, Issue 1

Abstract

Concurrent chemoradiotherapy (CCRT) is the foundational standard-of-care for patients with locoregionally advanced nasopharyngeal carcinoma (LANPC). Adding adjuvant chemotherapy (AC) or induction chemotherapy (IC) to CCRT has been shown to benefit LANPC patients. During recent five years, large numbers of prospective randomized controlled clinical trials have demonstrated the superior efficacy of IC+CCRT than CCRT alone in LANPC patients. However, prospectively designed studies concerned with AC are limited. The efficacy of CCRT+AC in treating LANPC remains unclear. For better understanding and more properly clinical usages of AC, we reviewed the studies of CCRT+AC in the treatments for LANPC patients. In summary, adding AC to CCRT is a feasible therapeutic strategy for patients with EBV positive LANPC.

Authors and Affiliations

Boya Xiao, Zhanjie Zhang, Bohua Kuang, Rubo Cao, Bicheng Wang

Keywords

Related Articles

A Commentary on the Natural Disease Progression Sequence of Chronic Hepatitis B

Hepatitis B virus (HBV), an ancient family of hepatotropic DNA viruses with origins dating back millions of years, remains a major burden to human health today, although hepatitis B vaccines have dramatically reduced the...

Characteristics of Patients with Cryptogenic Cirrhosis: A Retrospective Study

Backgrounds This study aimed to achieve a better understanding of the characteristics of patients with cryptogenic cirrhosis (CC). Methods We retrospectively enrolled 50 patients with CC between January 2018 and Decembe...

Research Advance in GP73 in the Clinical Diagnosis and Treatment of Patients with Chronic Hepatitis B

Golgi protein 73 (GP73) is a type II integrative membrane protein located in the cellular Golgi apparatus. Research shows, that in addition to protein processing, GP73 is involved in cell differentiation, intercellular s...

Is Preoperative Radiotherapy Necessary for Resectable Locally Advanced Squamous Cell Esophageal Carcinoma?

Based on the guidelines for esophageal and esophagogastric junction cancers, the standard of care for resectable locally advanced (cT2, N0 [high-risk lesions: lymphovascular invasion, ≥3 cm, poorly differentiated]; cT1b-...

Determination of mRNA Targets of miR-376c within the RNA-Induced Silencing Complex

Background The focus of the present study was to establish an easy combined method based on the MirTrap system together with a mRNA array to efficiently define target mRNAs which can be bound by miR-376 within the RNA-in...

Download PDF file
  • EP ID EP740189
  • DOI 10.54457/DR.202101001
  • Views 26
  • Downloads 1

How To Cite

Boya Xiao, Zhanjie Zhang, Bohua Kuang, Rubo Cao, Bicheng Wang (2021). Clinical Progress of Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma. Diseases & Research, 1(1), -. https://europub.co.uk/articles/-A-740189